Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 461239, 6 pages
http://dx.doi.org/10.1155/2014/461239
Clinical Study

Osteopontin and Osteoprotegerin as Potential Biomarkers in Abdominal Aortic Aneurysm before and after Treatment

1Department of Propedeutic Surgery, Hippokration Hospital, University of Athens Medical School, Vasilissis Sofias 114 Avenue, 11527 Athens, Greece
2Department of Pharmaceutical Chemistry, University of Athens School of Pharmacy, Vasilissis Sofias 114 Avenue, 11527 Athens, Greece

Received 10 April 2014; Accepted 11 May 2014; Published 9 July 2014

Academic Editor: Giuseppe Biondi-Zoccai

Copyright © 2014 Konstantinos Filis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Takayama and D. Yamanouchi, “Aneurysmal disease: the abdominal aorta,” Surgical Clinics of North America, vol. 93, no. 4, pp. 877–891, 2013. View at Publisher · View at Google Scholar
  2. L. Wang, J. Zhang, W. Fu, D. Guo, J. Jiang, and Y. Wang, “Association of smooth muscle cell phenotypes with extracellular matrix disorders in thoracic aortic dissection,” Journal of Vascular Surgery, vol. 56, no. 6, pp. 1698–1709, 2012. View at Publisher · View at Google Scholar
  3. T. Huusko, T. Salonurmi, P. Taskinen et al., “Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms,” The Journal of Thoracic and Cardiovascular Surgery, vol. 145, no. 4, pp. 1117–1123, 2013. View at Publisher · View at Google Scholar
  4. J. S. Lindholt, S. Vammen, H. Fasting, E. Henneberg, and L. Heickendorff, “The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study,” European Journal of Vascular and Endovascular Surgery, vol. 20, no. 3, pp. 281–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Shimizu, R. N. Mitchell, and P. Libby, “Inflammation and cellular immune responses in abdominal aortic aneurysms,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 5, pp. 987–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Shaheen and N. L. Weintraub, “Osteopontin: a bona fide mediator of abdominal aortic aneurysm?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 439–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Witkiewicz, A. Czyzewska-Buczyńska, S. Bałasz et al., “The role of osteopontin in cardiovascular diseases,” Polski Merkuriusz Lekarski, vol. 29, no. 170, pp. 79–83, 2010. View at Google Scholar
  8. J. Golledge, M. McCann, S. Mangan, A. Lam, and M. Karan, “Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis,” Stroke, vol. 35, no. 7, pp. 1636–1641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Mi, B. Nie, C. Zhang, and H. Zhou, “The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication,” Journal of Huazhong University of Science and Technology: Medical Science, vol. 31, no. 5, pp. 602–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ohmori, Y. Momiyama, H. Taniguchi et al., “Plasma osteopontin levels are associated with the presence and extent of coronary artery disease,” Atherosclerosis, vol. 170, no. 2, pp. 333–337, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. F. A. Hellenthal, W. A. Buurman, W. K. Wodzig, and G. W. H. Schurink, “Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation,” Nature Reviews: Cardiology, vol. 6, no. 8, pp. 543–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Bjerre, “Osteoprotegerin, (OPG) as a biomarker for diabetic cardiovascular complications,” SpringerPlus, vol. 2, article 658, 2013. View at Publisher · View at Google Scholar
  13. J. Golledge, J. Muller, N. Shephard et al., “Association between osteopontin and human abdominal aortic aneurysm,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 3, pp. 655–660, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-H. Zheng, C. Tian, Y. Meng et al., “Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells,” Journal of Cellular Physiology, vol. 227, no. 1, pp. 127–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Moran, P. Clancy, E. Biros et al., “Association of PPARγ allelic variation, osteoprotegerin and abdominal aortic aneurysm,” Clinical Endocrinology, vol. 72, no. 1, pp. 128–132, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Liang, H. Li, B. Hu et al., “Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer,” Chinese Journal of Cancer Research, vol. 23, no. 1, pp. 64–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. D. J. Caruso, A. J. K. Carmack, V. B. Lokeshwar, R. C. Duncan, M. S. Soloway, and B. L. Lokeshwar, “Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence,” Clinical Cancer Research, vol. 14, no. 13, pp. 4111–4118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Koopmann, N. S. Fedarko, A. Jain et al., “Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma,” Cancer Epidemiology, Biomarkers & Prevention, vol. 13, no. 3, pp. 487–491, 2004. View at Google Scholar · View at Scopus
  19. J. Agnholt, J. Kelsen, L. Schack, C. L. Hvas, J. F. Dahlerup, and E. S. Sørensen, “Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease,” Scandinavian Journal of Immunology, vol. 65, no. 5, pp. 453–460, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Mizutani, H. Matsubara, K. Yamamoto et al., “Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma,” Cancer, vol. 101, no. 8, pp. 1794–1802, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Roel, S. Johannes, L. H. Peter, and J. Buth, “Endovascular repair of abdominal aortic aneurysms with concomitant common iliac artery aneurysm: outcome analysis of the EUROSTAR experience,” Journal of Endovascular Therapy, vol. 15, no. 1, pp. 12–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Meng, C. Tian, L. Liu, L. Wang, and Q. Chang, “Elevated expression of connective tissue growth factor, osteopontin and increased collagen content in human ascending thoracic aortic aneurysms,” Vascular, vol. 22, no. 1, pp. 20–27, 2014. View at Publisher · View at Google Scholar
  23. D. Yamanouchi, Y. Takei, and K. Komori, “Balanced mineralization in the arterial system: possible role of osteoclastogenesis/osteoblastogenesis in abdominal aortic aneurysm and stenotic disease,” Circulation Journal, vol. 76, no. 12, pp. 2732–2737, 2012. View at Publisher · View at Google Scholar
  24. J. Golledge, B. Cullen, C. Rush et al., “Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm,” Atherosclerosis, vol. 210, no. 1, pp. 51–56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. P. Kadoglou, I. Papadakis, K. G. Moulakakis et al., “Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms,” Regulatory Peptides, vol. 179, no. 1–3, pp. 50–54, 2012. View at Publisher · View at Google Scholar
  26. R. Meenakshisundaram, S. Chandra, and P. Thirumalaikolundusubramanian, “Osteopontin and its clinical significance,” Indian Journal of Pathology & Microbiology, vol. 52, no. 3, p. 459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S.-M. Yuan, J. Wang, H.-R. Huang, and H. Jing, “Osteopontin expression and its possible functions in the aortic disorders and coronary artery disease,” Brazilian Journal of Cardiovascular Surgery, vol. 26, no. 2, pp. 173–182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Sbarouni, P. Georgiadou, C. Mihas, A. Chaidaroglou, D. Degiannis, and V. Voudris, “Significant peri-operative reduction in plasma osteopontin levels after coronary artery by-pass grafting,” Clinical Biochemistry, vol. 45, no. 16-17, pp. 1513–1515, 2012. View at Publisher · View at Google Scholar
  29. C. Suezawa, S. Kusachi, T. Murakami et al., “Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function,” The Journal of Laboratory and Clinical Medicine, vol. 145, no. 1, pp. 33–40, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Marjanović, M. Jevtić, S. Misović et al., “Early inflammatory response following elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional, open surgery,” Vojnosanitetski Pregled, vol. 68, no. 11, pp. 948–955, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Nanda, S. G. Sharma, and S. Longo, “Molecular targets and abdominal aortic aneurysms,” Recent Patents on Cardiovascular Drug Discovery, vol. 4, no. 2, pp. 150–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. C. S. Moran, M. McCann, M. Karan, P. Norman, N. Ketheesan, and J. Golledge, “Association of osteoprotegerin with human abdominal aortic aneurysm progression,” Circulation, vol. 111, no. 23, pp. 3119–3125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Koole, R. Hurks, A. Schoneveld et al., “Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 6, pp. 1497–1504, 2012. View at Publisher · View at Google Scholar